1.Jiang C, Qian C, Jiang Q, Zhou H, Jiang Z, Teng Y, Xu B,Li X, Ding C, Tian R . Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT. BMC medicine, 2025,23(1), 49-62.
2.Shuai Huang, Yumin Zhang, Yuekai Li, Chen-Ho Tung, Xin Li, Zhenghu Xu. Copper-catalyzed alkynyldisulfuration of arynes: efficient access to unsymmetrical disulfides. Org Chem Front., 2025,12,530-535
3.Li Y, Wang S, Zhao S, Zhao P, Huang S, Li K, Han S, Tian C,Li X, Shi B, Li X. Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence. Eur J Nucl Med Mol Imaging. 2024;51(8):2458-2466.
4.Wang J, Zhou Y, Zhou J, Liu H,Li X. Preliminary study on the ability of the machine learning models based on18F-FDG PET/CT to differentiate between mass-forming pancreatic lymphoma and pancreatic carcinoma. Eur J Radiol. 2024;176:111531.
5.Wang J, Zhou Y, Liu H, Zhou J,Li X.18F-FDG PET/CT assists the diagnosis of primary pancreatic lymphoma: Two case reports and literature review. Front Med (Lausanne). 2024 Feb 23;11:1370762.
6.Li K, Zhou Y, Zang M, Jin X,Li X. Therapeutic prospects of nectin-4 in cancer: applications and value. Front Oncol. 2024 Mar 28;14:1354543.
7.Li Y, Li F, Han S, Ning J, Su P, Liu J, Qu L, Huang S, Wang S,Li X, Li X. Performance of18F-DCFPyL PET/CT in Primary Prostate Cancer Diagnosis, Gleason Grading and D'Amico Classification: A Radiomics-Based Study. Phenomics. 2023 Jul 25;3(6):576-585.
8.Seki T, Yang Y, Sun X, Lim S, Xie S, Guo Z, Xiong W, Kuroda M, Sakaue H, Hosaka K, Jing X, Yoshihara M, Qu L,Li X, Chen Y, Cao Y. Brown-fat-mediated tumour suppression by cold-altered global metabolism.Nature. 2022 Aug;608(7922):421-428.
9.Sahakyan K,Li X, Lodge MA , Werner RA, Bundschuh RA , Bundschuh L , Kulkarni HR , Schuchardt C , Baum RP , Pienta KJ , Pomper MG, Ross AE , Gorin MA, Rowe SP. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake. Mol Imaging Biol. 2020 ;22(1):181-189
10.Rowe SP,Li X, Trock BJ , Werner RA, Frey S , DiGianvittorio M, Bleiler JK , Reyes DK , Abdallah R, Pienta KJ , Gorin MA, Pomper MG. Prospective Comparison of PET Imaging with PSMA-targeted18F-DCFPyL versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer. J Nucl Med, 2020 Feb;61(2):183-188.
11.Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, Pienta KJ, Lodge MA, Pomper MG. Semiquantitative Parameters in PSMA-Targeted PET Imaging with18F-DCFPyL: Variability in Normal-Organ Uptake, J Nucl Med, 2017, 58(6): 942- 946
12.Xin Li, Songtao Liu, Shuzhan Yao, Muwen Wang. A rare case of urachal mucinous adenocarcinoma detected by18F-FDG PET/CT. Clin Nucl Med, 2015,40 (3):282-285
13.Shaoling Liu, Bin Zhao, Jincai Ma, Jichang Li,Xin Li*. Lesions of biliary hamartoms can be diagnosed by ultrasonography, computed tomography and magnetic resonance imaging. Int J Clin Exp Med,2014;7(10):3370-3377
14.Hongchang Shen#,Xin Li#, Long Meng, Yang Ni, Guanghui Wang, Wei Dong, Jiajun Du*. Confirmation of histology of PET positive lymph nodes recovered by hand-video-assisted thoracoscopy surgery. Gene.2012, 509(1): 173-177
15.Xin Li, Qi Liu, Muwen Wang. C-11 Choline PET/CT Imaging for Differentiating Malignant From Benign Prostate Lesions. Clinical Nuclear Medicine，2008, 33(10):671-676
